Elevated levels of gremlin-1 in eutopic endometrium and peripheral serum in patients with endometriosis

Fertility and Sterility

Volumn 91, Issue 2, 2009, Pages 350-358

  Sha, Guihua ^a   Zhang, Yan ^a   Zhang, Chengyan ^a   Wan, Yuping ^b   Zhao, Zhengmiao ^b   Li, Chunyan ^a   Lang, Jinghe ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b Phoenix Biotech (Beijing) Co Ltd   (China)

Author keywords

angiogenesis; ELISA; Endometriosis; gremlin 1; HEEC

Indexed keywords

BIOLOGICAL MARKER; CD146 ANTIGEN; GREMLIN 1 PROTEIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOMETRIOSIS; ENDOMETRIUM; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; INTRACELLULAR SPACE; MENSTRUAL CYCLE; OVARY FOLLICLE CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; WESTERN BLOTTING;

ADULT; ANTIGENS, CD146; BIOLOGICAL MARKERS; BLOTTING, FAR-WESTERN; CASE-CONTROL STUDIES; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PILOT PROJECTS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 59249094398     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.12.007     Document Type: Article

References (39)

1. Tang X.J., Lang J.H., Shen K., Liu Z.F., Sun D.W., Leng J.H., et al. Operative approaches indications, and medical economics evaluation of 4180 cases of hysterectomy. Zhongquo Yi Xue Ke Xue Yuan Xue Bao 25 (2003) 406-409
2. Sampson J.A. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14 (1927) 422-429
3. Groothuis P.G., Nap A.W., Winterhager E., and Grümmer R. Vascular development in endometriosis. Angiogenesis 8 (2005) 147-156
4. Nisolle M., Casanas-Roux F., Anaf V., Mine J.M., and Donnez J. Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil Steril 59 (1993) 681-684
5. Nap A.W., Griffioen A.W., Dunselman G.A., Bouma-Ter Steege J.C., Thijssen V.L., Evers J.L., et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 89 (2004) 1089-1095
6. Laschke M.W., Elitzsch A., Scheuer C., Holstein J.H., Vollmar B., Menger M.D., et al. Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation. Br J Pharmacol 149 (2006) 137-144
7. Sha G., Wu D., Zhang L., Chen X., Lei M., Sun H., et al. Differentially expressed genes in human endometrial endothelial cells derived from eutopic endometrium of patients with endometriosis compared with those from patients without endometriosis. Hum Reprod 22 (2007) 3159-3169
8. Noyes R.W., Hertig A.T., and Rock J. Dating the endometrial biopsy. Fertil Steril 1 (1950) 3-5
9. Wordinger R.J., Agarwal R., Talati M., Fuller J., Lambert W., and Clark A.F. Expression of bone morphogenetic proteins (BMP), BMP receptor, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol Vis 8 (2002) 241-250
10. Stabile H., Mitola S., Moroni E., Belleri M., Nicoli S., Presta M., et al. Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood 109 (2007) 1834-1840
11. Gambino L.S., Wreford N.G., Bertram J.F., Dockery P., Lederman F., and Rogers P.A. Angiogenesis occurs by vessel elongation in proliferative phase human endometrium. Hum Reprod 17 (2002) 1199-1206
12. Khokha M.K., Hsu D., Brunet L.J., Dionne M.S., Harland R.M., et al. Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet 34 (2003) 303-307
13. Merino R., Rodriguez-Leon J., Macias D., Gañan Y., Economides A.N., Hurle J.M., et al. The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development 26 (1999) 5515-5522
14. Michos O., Panman L., Vintersten K., Beier K., Zeller R., and Zuniga A. Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131 (2004) 3401-3410
15. Kueh J., Richards M., Ng S.W., Chan W.K., and Bongso A. The search for factors in human feeders that support the derivation and propagation of human embryonic stem cells: preliminary studies using transcriptome profiling by serial analysis of gene expression. Fertil Steril 85 (2006) 1843-1846
16. Wade F.M., Wakade C., Mahesh V.B., and Bran D.W. Differential expression of the peripheral benzodiazepine receptor and gremlin during adipogenesis. Obes Res 13 (2005) 818-822
17. Frank N.Y., Kho A.T., Schatton T., Murphy G.F., Kohane I.S., Gussoni E., et al. Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP-4 and its antagonist Gremlin. J Cell Biol 175 (2006) 99-110
18. Cho N.H., Park Y.K., Kim Y.T., Yang H., and Kim S.K. Lifetime expression of stem cell markers in the uterine endometrium. Fertil Steril 81 (2004) 403-407
19. Chan R.W., Schwab K.E., and Gargett C.E. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod 70 (2004) 1738-1750
20. In 't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., de Groot-Swings G.M., Claas F.H., Fibbe W.E., et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22 (2004) 1338-1345
21. Schwab K.E., Chan R.W., and Gargett C.E. Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle. Fertil Steril 84 Suppl 2 (2005) 1124-1130
22. Kato K., Yoshimoto M., Adachi S., Yamayashi A., Arima T., Wake N., et al. Characterization of side-population cells in human normal endometrium. Hum Reprod 22 (2007) 1214-1223
23. Taylor H.S. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 292 (2004) 81-85
24. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 (2000) 389-395
25. Asahara T., Murohara T., Sullivan A., Silver M., Witzenbichler B., Isner J.M., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
26. Doyle B., Metharom P., and Caplice N.M. Endothelial progenitor cells. Endothelium 13 (2006) 403-410
27. Grümmer R., Schwarzer F., Bainczyk K., Hess-Stumpp H., Regidor P.A., Schindler A.E., et al. Peritoneal endometriosis: validation of an in-vivo model. Hum Reprod 16 (2001) 1736-1743
28. Hull M.L., Charnock-Jones D.S., Chan C.L., Bruner-Tran K.L., Osteen K.G., Smith S.K., et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 88 (2003) 2889-2899
29. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 6 (2000) 45-55
30. Masuda H., Maruyam T., Hiratsu E., Yamane J., Iwanami A., Yoshiura Y., et al. Noninvasive and real-time assessment of reconstructed functional human endometrium in NOD/SCID/gamma c(null) immunodeficient mice. Proc Natl Acad Sci USA 104 (2007) 1925-1930
31. Martínez S., Garrido N., Coperias J.L., Pardo F., Desco J., Pellicer A., et al. Serum interleukon-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod 22 (2007) 836-842
32. Gagné D., Rivard M., Pagé M., Lépine M., Platon C., Gosselin D., et al. Development of a nonsurgical diagnostic tool for endometriosis based on the detection of endometrial leukocyte subsets and serum CA-125 level. Fertil Steril 80 (2003) 876-885
33. Agic A., Xu H., Rehbein M., Wolfler M.M., Ebert A.D., and Hornung D. Cognate chemokine receptor 1 messenger ribonucleic acid expression in peripheral blood as a diagnostic test for endometriosis. Fertil Steril 87 (2007) 982-984
34. McKenzie L.J., Pangas S.A., Carson S.A., Kovanci E., Cisneros P., and Matzuk M.M. Human cumulus granulosa cell gene expression: a predictor of fertilization and embryo selection in women undergoing IVF. Hum Reprod 19 (2004) 2869-2874
35. Topol L.Z., Bardot B., Zhang Q., Resau J., Huillard E., Blair D.G., et al. Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin. J Biol Chem 275 (2000) 8785-8793
36. McMahon R., Murphy M., Clarkson M., Taal M., Mackenzie H.S., Brady H.R., et al. IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta 1. J Biol Chem 275 (2000) 9901-9904
37. Lappin D.W., Hensey C., McMahon R., Godson C., and Brady H.R. Gremlins, glomeruli and diabetic nephropathy. Curr Opin Nephrol Hypertens 9 (2000) 469-472
38. Koli K., Myllärniemi M., Vuorinen K., Salmenkivi K., Ryynänen M.J., Keski-Oja J., et al. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic fibrosis. Am J Pathol 169 (2006) 61-71
39. Sneddon J.B., Zhen H.H., Montgomery K., van de Rijn M., Tward A.D., Brown P.O., et al. Bone morphogenesis protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci USA 103 (2006) 14842-14847